LIONEX DIAGNOSTICS AND THERAPEUTICS
LIONEX has introduced a new IGRA test for LTBI/TB called LIONEX®TB/LTBI
The complete EndoTrap® product range as well as EndoGrade® Ovalbumin have been discontinued by Hyglos as of 31 December 2017, instead LIONEX GmbH, Braunschweig, Germany, is now the manufacturer and exclusive supplier of these products.
EndoTrap® family: Endotoxin removal products are now available from LIONEX, Braunschweig, GERMANY
World's Leading Producer And Source Of Mycobacterial Antigens For Diagnostics And Vaccine Development
LIONEX is a German biotech company active in the fields of biomedicine and human health with special emphasis on TUBERCULOSIS (TB). Our focus is on research and In-Vitro-Diagnostic (IVD) product development for infectious diseases and cancer. LIONEX has recently launched a new IGRA (Interferon Gamma Release Assay) diagnostic test called LIOFeron®TB/LTBI for LTBI (Latent Tuberculosis Infection). It may also react positive in TB patients also but, as for other similar IGRA tests on the market, it cannot differentiate between LTBI and active TB.
LIONEX is a leading manufacturer of highly purified, endotoxin free, mycobacterial antigens for research on tuberculosis and other mycobacterial diseases.
LIONEX is the licensed, exclusive manufacturer and distributor of a widely known family of endotoxin removal resin under the brand name EndoTrap®. EndoGrade®Ovalbumin is another useful product for research on vaccine development.
Bovine tuberculosis tests are also available for research.
LIONEX has state of the manufacturing facilities for IVD-Lateral Flow Tests. All products are manufactured in Germany. All productions are done under ISO13485 certified conditions.
We are a highly reliable partner for OEM products for companies active in manufacturing and distribution of such products worldwide.
LIONEX partners and clients are large diagnostic companies, distributors, research institutions, universities, hospitals located on all continents.